TWI309563B - - Google Patents
Download PDFInfo
- Publication number
- TWI309563B TWI309563B TW95142518A TW95142518A TWI309563B TW I309563 B TWI309563 B TW I309563B TW 95142518 A TW95142518 A TW 95142518A TW 95142518 A TW95142518 A TW 95142518A TW I309563 B TWI309563 B TW I309563B
- Authority
- TW
- Taiwan
- Prior art keywords
- egg
- virus
- eggs
- day
- antigen
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 52
- 235000013601 eggs Nutrition 0.000 claims description 47
- 206010064097 avian influenza Diseases 0.000 claims description 19
- 208000002979 Influenza in Birds Diseases 0.000 claims description 16
- 210000002969 egg yolk Anatomy 0.000 claims description 15
- 102000002322 Egg Proteins Human genes 0.000 claims description 12
- 108010000912 Egg Proteins Proteins 0.000 claims description 12
- 241000287828 Gallus gallus Species 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 12
- 102000036639 antigens Human genes 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 12
- 235000013345 egg yolk Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 229960005486 vaccine Drugs 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 230000034994 death Effects 0.000 claims description 5
- 231100000517 death Toxicity 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 210000002257 embryonic structure Anatomy 0.000 claims description 4
- 241000272525 Anas platyrhynchos Species 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 210000001161 mammalian embryo Anatomy 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 229940031551 inactivated vaccine Drugs 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 230000017448 oviposition Effects 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 description 18
- 206010022000 influenza Diseases 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004520 agglutination Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000143437 Aciculosporium take Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 102000018265 Virus Receptors Human genes 0.000 description 1
- 108010066342 Virus Receptors Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 244000240602 cacao Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200822909A TW200822909A (en) | 2008-06-01 |
| TWI309563B true TWI309563B (enExample) | 2009-05-11 |
Family
ID=44770911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW200822909A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894397A (zh) * | 2011-07-27 | 2013-01-30 | 郑长义 | 禽流感免疫鸡蛋生产的方法 |
-
2006
- 2006-11-17 TW TW95142518A patent/TW200822909A/zh not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894397A (zh) * | 2011-07-27 | 2013-01-30 | 郑长义 | 禽流感免疫鸡蛋生产的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200822909A (en) | 2008-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus | Update on avian influenza A (H5N1) virus infection in humans | |
| CN101880651B (zh) | 番鸭细小疫苗的制备方法 | |
| CN108567975A (zh) | 胃肠外诺如病毒疫苗配制剂 | |
| CN105968195B (zh) | 一种抗流感病毒的鸡卵黄抗体及其制备方法 | |
| Tian et al. | Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam | |
| CN104884085A (zh) | 用于免疫低下群体的疫苗组合物 | |
| CN102233133A (zh) | 一种新城疫病毒感染免疫复合物疫苗的制备方法和应用 | |
| CN107050448A (zh) | 一种禽流感病毒、禽腺病毒二联灭活疫苗的制备方法 | |
| CN104928259A (zh) | 一种h9亚型禽流感病毒、灭活疫苗及其制备方法 | |
| CN102302775B (zh) | 鸡新城疫与h9亚型禽流感二联灭活疫苗及其制备方法 | |
| CN109419804B (zh) | 一种畜禽用抗病毒感染的植物源制剂 | |
| CN100572532C (zh) | 一种鸭瘟疫苗及其专用毒株 | |
| TWI309563B (enExample) | ||
| CN105770892A (zh) | 一种防治鸡心包积液-肝炎综合征生物兽药的制备方法 | |
| CN106065030B (zh) | 鸡包涵体肝炎的卵黄抗体及其制备方法 | |
| Kumosani et al. | Evaluation in broilers of aerosolized nanoparticles vaccine encapsulating imuno-stimulant and antigens of avian influenza virus/Mycoplasma gallisepticum | |
| CN107375920A (zh) | 一种猪繁殖与呼吸综合症病毒‑猪流感病毒重构病毒体疫苗及其制备方法和用途 | |
| CN102166355A (zh) | 一种用于预防鸡疾病的四联灭活疫苗 | |
| Arif et al. | Seroprevalence of avian influenza in broilers of District Quetta, Balochistan, Pakistan | |
| RU2017110225A (ru) | Способ получения вакцинных антигенов, получаемые вакцинные антигены и их применение | |
| CN103497933B (zh) | 一株h9n2型禽流感毒株在疫苗开发上的应用 | |
| CN101025420B (zh) | 一种禽流感病毒乳胶凝集检测试剂盒及应用 | |
| CN102973936A (zh) | 壳聚糖在制备禽用疫苗组合物中的应用 | |
| TWI300807B (en) | Attenuated avian infectious bronchitis virus vaccines | |
| CN101914500A (zh) | 基因重组的h9n1亚型禽流感病毒及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees | ||
| MM4A | Annulment or lapse of patent due to non-payment of fees |